Debunked Episode 30: ACCESS Tries to Succeed Where VBC Fails, AI, and UnitedHealth Gets the Last Week Tonight Treatment

Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed the merits of the CMS ACCESS Model (Advancing Chronic Care with Effective, Scalable Solutions) and how it can offer a path to advance value-based care goals. The post Debunked Episode 30: ACCESS Tries to Succeed Where VBC Fails, AI, and UnitedHealth Gets the Last Week Tonight…

Read More

Pfizer Pill’s Phase 3 Data in Vitiligo Pave Way for FDA, EMA Submissions

Pfizer’s Litfulo significantly improved skin pigment measures in two pivotal studies in vitiligo, results that were presented during European Academy of Dermatology and Venereology annual meeting. If Pfizer’s daily pill is approved, it would compete against an Incyte topical cream that is currently the only FDA-approved therapy for this autoimmune skin disorder. The post Pfizer…

Read More

It’s Time We Reframe Healthcare Organizational Culture Using Behavioral Science

Data, behavioral insights, and experimentation can be used to understand how stress, motivation, and trust shape company culture. Positively changing company culture leads to direct improvements in patient health outcomes, clinician wellbeing, and company performance. The post It’s Time We Reframe Healthcare Organizational Culture Using Behavioral Science appeared first on MedCity News.

Read More

Midterms Have Revived Universal Healthcare Debate. These States Are Ahead of Everyone.

Democratic congressional members and candidates are already planning to use any midterm election gains to expand health coverage, including boosting Affordable Care Act subsidies, reversing Medicaid cuts, and lowering the Medicare eligibility age. But Democratic strongholds across the country — including Oregon, California, New York, and Washington — have more ambitious goals: single-payer, universal healthcare…

Read More

You Say “AI,” I Hear “Organoid”

By KIM BELLARD I must admit, ever since I learned about, and wrote about (OI May Be the New AI), “organoid intelligence” over three years ago, I’ve been looking to do a follow-up. I mean, sure, AI is in a very exciting stage, but that stage no longer seems like the future; it seems more…

Read More